Lonaprofen

Lonaprofen

SCHEMBL29670159

COC(=O)C(C)Oc1ccc2ccccc2c1Cl

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCEH1 Q6PIU2 8/20 0.56
LMNA P02545 4/20 0.56
SMN1; SMN2 Q16637 3/20 0.52
NPC1 O15118 2/20 0.46
TP53 P04637 2/20 0.46
RAB9A P51151 2/20 0.46
POLB P06746 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
HPGD P15428 1/20 0.45
CASP3 P42574 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
F9 P00740 1/20 0.43
PLAU P00749 1/20 0.43
CYP2A6 P11509 1/20 0.42
MAPT P10636 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lonaprofen SCHEMBL2109183 1.00 NCEH1 (0.56) NCEH1LMNASMN1; SMN2NPC1TP53
SCHEMBL11810433 0.86 LMNA (0.53) NCEH1LMNASMN1; SMN2NPC1TP53
SCHEMBL11807492 0.84 LMNA (0.55) NCEH1LMNASMN1; SMN2NPC1TP53
SCHEMBL11807725 0.84 NCEH1 (0.54) NCEH1LMNASMN1; SMN2NPC1TP53
SCHEMBL11798018 0.84 LMNA (0.51) NCEH1LMNASMN1; SMN2NPC1TP53
SCHEMBL11804487 0.83 LMNA (0.47) NCEH1LMNASMN1; SMN2NPC1TP53
SCHEMBL11800432 0.82 LMNA (0.49) NCEH1LMNASMN1; SMN2NPC1TP53
SCHEMBL23368144 0.79 TSHR (0.54) LMNASMN1; SMN2NPC1RAB9AL3MBTL1
SCHEMBL18331090 0.79 TSHR (0.54) LMNASMN1; SMN2NPC1RAB9AL3MBTL1
SCHEMBL13390983 0.78 MAPT (0.58) NCEH1LMNASMN1; SMN2NPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110713489-B Heteroaryl SYK inhibitors 勃林格殷格翰国际有限公司 2022-05-31 CN disclosed